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Methods (continued)

Discussion

vDuring total knee arthroplasty (TKA), whether or not one
should routinely resurface the patella is controversial.

vDecision of whether or not to resurface the patella during
primary TKA remains controversial

vLeaving an unresurfaced patella following index TKA may
lead to anterior knee pain (AKP), patellofemoral crepitus,
and future secondary resurfacing operations.

vThe pooled data of this analysis agrees with literature that
routine PR is cost effective.2
vTwo separate level-one studies have demonstrated no
difference in the incidence of AKP or need for secondary
surgery in patients without significant patellar cartilage
wear.3,4

vHowever, routinely resurfacing the patella (PR) may lead to
patellar fracture, aseptic loosening, patellar instability,
avascular necrosis, and patellar clunk.

vFrom our pooled results, incremental cost per QALY for PR
was $3,032- a reasonable cost. However, when considering
routine PR in patients without significant patellar wear, the
cost per QALY dramatically increased to $183,584– outside
of the accepted norm.

vThe purpose of the present study is to utilize the existing level
one evidence to assess the cost-utility of routine patella
resurfacing during primary TKA.
vHypothesis: Selective resurfacing of the patella is more cost
effective than routine patellar resurfacing during primary TKA.

vOne study investigating selective PR found only 34.4% of
patients met their criteria of Outerbridge Grade IV arthritis.5

Methods

Systematic
Review

vAdopting these findings here, we show that the cost
avoidance in the USA if patellae are not resurfaced in 66% of
TKA recipients without patellar arthritis could be
108,559,370 annually

Preoperative Data:
Year, Exclusion
Criterion, length and
proportion of followup, criteria to perform
PR, preoperative
functional scores
Postoperative Data:
Functional scores, rate
of AKP, delayed patellar
resurfacing,
reoperation for
maltracking, and
revision for patellarelated complications

vLimitations: importance of accurate utility scores, variation
in costs, and limited study duration to 5 years

Results
Decision Tree
Analysis

vThe potential outcome events that may be associated with a
decision to resurface the patella during TKA were defined
(See Figure 1: Sample of Decision Tree for each analysis)
vTwo analyses were performed: 1) Included all studies that
qualified per the systematic review; 2) Used probabilities
based upon those studies in which randomization was
performed among patients without evidence of patellar
arthritis (selective PR)
vQuality adjusted life year scores (QALY)1 spanning 5 years
were calculated based on literature-based cost estimates

v 14 prospective randomized controlled studies were included
combining 3,562 patients undergoing 3,823 TKAs
v Combining all studies: persistent AKP postop found in 20.9%
unresurfaced vs 13.2% of resurfaced patellae (p<0.001)
v Reoperation for patellar pathology occurred in 3.7% of
unresurfaced versus 1.6% resurfaced patellae (p<0.001)
v However, when analyzing only studies that excluded
arthritic patellae, post op AKP was equivalent between
unresurfaced vs resurfaced groups (p=0.97)
v Across all studies, routine PR showed improved utility scores
for the five-year post-arthroplasty period (2.94 versus 2.87)
v In considering routine resurfacing in patients without
arthritis, the utility output was 3.06 and only 0.0013 points
improved over the patella retention.
v At a cost of $329 (PR) vs $90.34 (retention), the
incremental cost per QALY achieved increased to $183,584

Conclusion
vThis cost effectiveness analysis shows that it is not cost
effective to routinely resurface the non-arthritic patella
during primary TKA
vWe show that selective PR may provide a more effective
means of maxing benefits and minimizing the risk of
complications
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